What is COVAX?
COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) AcceleratorThe ACT Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
What is the v-safe app for COVID-19 vaccinations?
v-safe is a smartphone-based tool that uses text messaging and web surveys to provide personalized health check-ins after you receive a COVID-19 vaccine.
What is the emergency use authorization for a vaccine?
Put simply, an emergency use authorization (EUA) is a tool the Food and Drug Administration (FDA) can use to expedite the availability of medical products, including drugs and vaccines, during a public health emergency.
What is COVAX in the context of COVID-19?
COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. The ACT Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
What is the Covax facility for COVID-19 vaccines?
The COVAX Facility is the global pooled procurement mechanism for COVID-19 vaccines through which COVAX will ensure fair and equitable access to vaccines for all 190 participating economies, using an allocation framework formulated by WHO.
Is it safe for women to take the Moderna or Pfizer COVID-19 vaccine?
The Centers for Disease Control and Prevention (CDC) recommend most adult women receive a two-shot primary series of either the Pfizer-BioNTech or Moderna mRNA COVID-19 vaccines, followed by a booster dose at least five months after the last primary dose.
Is there an emergency use authorization for the Moderna COVID-19 vaccine?
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, MODERNA COVID-19 VACCINE, for active immunization to prevent COVID-19 in individuals 18 years of age and older.
What is Emergency Use Authorization (EUA) in the context of the COVID-19 pandemic?
The FDA can issue EUA during a public health emergency—like a pandemic—to allow the use of unapproved medical products to diagnose, treat or prevent serious or life-threatening diseases. Prior to issuing EUA, safety and efficacy must be demonstrated and certain FDA criteria must be met; there also must be evidence that strongly suggests that patients have benefited from a treatment or test, and there are no adequate, approved or available alternatives.
What is the Covax initiative for the development of COVID-19 vaccine?
COVAX aims to accelerate the development and manufacturing of COVID-19 vaccines, and guarantee fair and equitable access for every country. COVAX is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi and WHO, with UNICEF as a key delivery partner and PAHO as the procurement agent in the Americas.